These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33130376)

  • 1. Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking.
    Xi X; Sun W; Su H; Zhang X; Sun F
    Mol Immunol; 2020 Dec; 128():165-174. PubMed ID: 33130376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.
    Roovers RC; Vosjan MJ; Laeremans T; el Khoulati R; de Bruin RC; Ferguson KM; Verkleij AJ; van Dongen GA; van Bergen en Henegouwen PM
    Int J Cancer; 2011 Oct; 129(8):2013-24. PubMed ID: 21520037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival.
    Tabtimmai L; Suphakun P; Srisook P; Kiriwan D; Phanthong S; Kiatwuthinon P; Chaicumpa W; Choowongkomon K
    J Cell Biochem; 2019 Oct; 120(10):18077-18087. PubMed ID: 31172597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paper Title "Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody".
    Sharifi J; Khirehgesh MR; Akbari B; Soleymani B; Mansouri K
    Mol Biotechnol; 2021 Jun; 63(6):525-533. PubMed ID: 33772436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
    Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
    Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.
    Voigt M; Braig F; Göthel M; Schulte A; Lamszus K; Bokemeyer C; Binder M
    Neoplasia; 2012 Nov; 14(11):1023-31. PubMed ID: 23226096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
    Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
    Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of camel nanobodies specific for superfolder GFP fusion proteins.
    Twair A; Al-Okla S; Zarkawi M; Abbady AQ
    Mol Biol Rep; 2014 Oct; 41(10):6887-98. PubMed ID: 25085037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into a high affinity nanobody:antigen complex by homology modelling.
    Skottrup PD
    J Mol Graph Model; 2017 Sep; 76():305-312. PubMed ID: 28779687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
    Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
    Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
    Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
    Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.
    Sharifzadeh Z; Rahbarizadeh F; Shokrgozar MA; Ahmadvand D; Mahboudi F; Rahimi Jamnani F; Aghaee Bakhtiari SH
    Mol Biotechnol; 2013 Jun; 54(2):590-601. PubMed ID: 23015323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
    Xia X; M M; Zhai T; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a nanobody against HER2 tyrosine kinase using phage display library screening for HER2-positive breast cancer therapy development.
    Lamtha T; Tabtimmai L; Bangphoomi K; Kiriwan D; Malik AA; Chaicumpa W; van Bergen En Henegouwen PMP; Choowongkomon K
    Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 34908139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing and constructing a phage display synthesized single domain antibodies library based on camel VHHs frame for screening and identifying humanized TNF-α-specific nanobody.
    Nie J; Ma X; Hu F; Miao H; Feng X; Zhang P; Han MH; You F; Yang Y; Zhang W; Zheng W
    Biomed Pharmacother; 2021 May; 137():111328. PubMed ID: 33571835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38
    Fumey W; Koenigsdorf J; Kunick V; Menzel S; Schütze K; Unger M; Schriewer L; Haag F; Adam G; Oberle A; Binder M; Fliegert R; Guse A; Zhao YJ; Cheung Lee H; Malavasi F; Goldbaum F; van Hegelsom R; Stortelers C; Bannas P; Koch-Nolte F
    Sci Rep; 2017 Oct; 7(1):14289. PubMed ID: 29084989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric inhibition of VIM metallo-β-lactamases by a camelid nanobody.
    Sohier JS; Laurent C; Chevigné A; Pardon E; Srinivasan V; Wernery U; Lassaux P; Steyaert J; Galleni M
    Biochem J; 2013 Mar; 450(3):477-86. PubMed ID: 23289540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction of camelidae natural nanobody phage dispaly library and screening, production and identification of anti-CD19 nanobody].
    Li G; Li Y; Chu Y; Zhang A; Pan J; Wang H; Xu G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1036-1043. PubMed ID: 33210599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.